Metraipolis › archive › dc_dff4a7b8409e

Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40429476
DOI
10.3390/jcm14103481
License (as archived)
solo-consultazione
Archived
2026-10-15T16:34:42.584Z
SHA-256 of the archived text
f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460
Stable URL of this page
https://metraipolis.com/documento/dc_dff4a7b8409e

How to cite

Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476 — Europe PMC (en), https://europepmc.org/article/MED/40429476 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dff4a7b8409e (Metraipolis archive dc_dff4a7b8409e, sha256 f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460)
BibTeX
@misc{dcdff4a7b8409e,
  title = {Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40429476},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dff4a7b8409e; sha256 f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40429476. Agents can read the archived copy with the MCP tool read_document.